| pubmed-article:15016308 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0042900 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0002085 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0008897 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:15016308 | lifeskim:mentions | umls-concept:C0549217 | lld:lifeskim |
| pubmed-article:15016308 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15016308 | pubmed:dateCreated | 2004-3-12 | lld:pubmed |
| pubmed-article:15016308 | pubmed:abstractText | As is the case with many other autoimmune diseases, there is an association between vitiligo and HLA complex. HLA subtypes vary with racial/ethnic background. The purpose of this study was to determine which HLA class I antigens and HLA class II alleles are associated with Turkish vitiligo patients. Forty-one patients with vitiligo and 61 healthy control subjects were typed for HLA class II alleles. Thirty-three out of 41 patients with vitiligo and 100 healthy transplant donors were typed for HLA class I antigens. HLA DNA typing was performed by polymerase chain reaction/sequence specific primer method for class II. HLA typing for class I was performed by serological method. The frequency of HLA DRB1*03 was 0.6340 in patients compared to 0.2950 in controls (P = 0.0014). The frequency of HLA DRB1*04 was found to be 0.6830 in patients compared to 0.2950 in controls (P = 0.00026). The allele HLA DRB1*07 was present in 0.390 of patients compared to 0.0820 of the controls (P = 0.0004). A preventive antigen for the manifestation of vitiligo has not been identified in this study. Our findings suggest that DRB1*03, DRB1*04 and DRB1*07 alleles are genetic markers for general susceptibility to vitiligo in a Turkish population. | lld:pubmed |
| pubmed-article:15016308 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15016308 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15016308 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15016308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15016308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15016308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15016308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15016308 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15016308 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15016308 | pubmed:issn | 0893-5785 | lld:pubmed |
| pubmed-article:15016308 | pubmed:author | pubmed-author:AkarAhmetA | lld:pubmed |
| pubmed-article:15016308 | pubmed:author | pubmed-author:InalAliA | lld:pubmed |
| pubmed-article:15016308 | pubmed:author | pubmed-author:ArcaErcanE | lld:pubmed |
| pubmed-article:15016308 | pubmed:author | pubmed-author:Ta?tanHalis... | lld:pubmed |
| pubmed-article:15016308 | pubmed:author | pubmed-author:Orkuno?luFund... | lld:pubmed |
| pubmed-article:15016308 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15016308 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:15016308 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15016308 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15016308 | pubmed:pagination | 181-4 | lld:pubmed |
| pubmed-article:15016308 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:meshHeading | pubmed-meshheading:15016308... | lld:pubmed |
| pubmed-article:15016308 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15016308 | pubmed:articleTitle | Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. | lld:pubmed |
| pubmed-article:15016308 | pubmed:affiliation | Department of Dermatology, Gulhane Military Medical Academy School of Medicine, Etlik, Ankara, Turkey. btastan@gata.edu.tr | lld:pubmed |
| pubmed-article:15016308 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:3123 | entrezgene:pubmed | pubmed-article:15016308 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15016308 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15016308 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15016308 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15016308 | lld:pubmed |
